American Airlines heads into mid-August with a striking disconnect: short sellers are pulling back at pace, yet the stock has still lost 7% on the week.
The short interest story is the standout this week, and it runs against the price trend. Bearish positioning has fallen sharply — SI dropped nearly 18% over the past seven days to 8.7% of the free float, unwinding a position that peaked above 10.5% of the float in late July. That's a meaningful retreat, roughly 12 million shares covered in under two weeks. The lending market reflects the same dynamic. Availability has loosened dramatically, climbing to 1,451% — meaning shares available to borrow now dwarf the amount currently lent out by a factor of fourteen. Cost to borrow has eased in parallel, falling 15% on the week to just 0.40%. None of this points to a crowded short trade. It looks more like an orderly unwind. Options positioning adds a wrinkle: the put/call ratio ticked up to 1.68 on Friday, above its 20-day average of 1.57 and about 1.4 standard deviations elevated, suggesting some residual demand for downside protection even as outright short interest retreats. The ORTEX short score has drifted lower too, easing from the mid-46s to 43 over the past ten days — consistent with the positioning unwind rather than fresh conviction.
The Street picture is mixed and skewed toward caution following July earnings. Most moves post-Q2 were in one direction: lower targets. UBS kept its Buy but trimmed to $18 from $21. Goldman maintained its Sell and cut to $13. Citi stayed at Buy but dropped to $19 from $22. JPMorgan was the outlier, raising to $24 while holding Overweight — the most bullish single call in the pack. The consensus mean target works out near $19, roughly 28% above the current $14.83 close, but the gap between the bull ($24–$25) and bear ($13) camps is wide enough to suggest genuine disagreement rather than lazy dispersion. Valuation offers limited clarity: the trailing PE is around 9.6x and the EV/EBITDA has edged up 0.15 turns over 30 days to 6.5x, neither stretched nor compelling in isolation. EPS momentum ranks in the 99th percentile versus the broader universe — the company has been consistently beating estimates — but the ev/ebit factor score ranks in just the 11th percentile, flagging the debt load that has dogged the name all year.
Insider activity reinforces the cautious read. The Executive Deputy Chairman sold 30,000 shares per day across five consecutive sessions in late July, totalling around $2.3 million in proceeds. The COO sold over $1.2 million earlier in the summer. Net insider activity over the past 90 days is positive in share terms only because of awards; actual open-market selling has been consistent and directional. None of these are enormous transactions relative to the company's float, but the pattern — senior executives selling methodically into every mild rally — is not the signal a bull wants to see.
Peer context puts the week in sharper relief. DAL fell 2.2% on the day Friday and 2.2% on the week. UAL lost 3.3% for the week. ALK and ALGT fared worse, down 8% and 10% respectively. Weakness is sector-wide, and AAL's 7% weekly drop puts it toward the worse end of the peer group rather than the outlier it sometimes is. The most recent earnings print — Q2, reported July 23 — saw the stock fall 2.1% the day after, then recover 4.3% over the following five days. The prior quarter was far more punishing: a one-day drop of 11.3%. The market is at least not treating this management team with the same severity it did in April.
What to watch next: whether the short-covering trend continues at pace or stalls around the 8–9% of float range, and whether the divergence between retreating SI and a still-falling stock price eventually resolves through price catching up to positioning — or positioning rebuilding to match price.
See the live data behind this article on ORTEX.
Open AAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
